We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$7.02M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$6.58M
3
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$4.15M
4
BAC icon
Bank of America
BAC
+$3.47M
5
THO icon
Thor Industries
THO
+$3.15M

Top Sells

Rank Stock Value
1
FMI
Foundation Medicine, Inc.
FMI
+$63.6M
2
GILD icon
Gilead Sciences
GILD
+$42.5M
3
AFL icon
Aflac
AFL
+$39.9M
4
KMX icon
CarMax
KMX
+$23.6M
5
WLY icon
John Wiley & Sons Class A
WLY
+$19.2M

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAD
1276
DELISTED
Rite Aid Corporation
RAD
$127K ﹤0.01%
3,660
-350
-9% -$11.9K
HIE
1277
DELISTED
Miller/Howard High Income Equity Fund
HIE
$126K ﹤0.01%
10,500
– –
JPS
1278
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$126K ﹤0.01%
14,325
+1,915
+15% +$18K
IRT icon
1279
Independence Realty Trust
IRT
$3.93B
$124K ﹤0.01%
12,062
– –
SAN icon
1280
Banco Santander
SAN
$202B
$120K ﹤0.01%
23,534
-5,097
-18% -$29.8K
IQI icon
1281
Invesco Quality Municipal Securities
IQI
$528M
$119K ﹤0.01%
10,000
– –
JRS icon
1282
Nuveen Real Estate Income Fund
JRS
$250M
$110K ﹤0.01%
+11,038
New +$108K
ESV
1283
DELISTED
Ensco Rowan plc
ESV
$110K ﹤0.01%
3,797
-195
-5% -$4.77K
AG icon
1284
First Majestic Silver
AG
$7.75B
$108K ﹤0.01%
14,089
-359
-2% -$2.51K
SNDX icon
1285
Syndax Pharmaceuticals
SNDX
$1.73B
$107K ﹤0.01%
15,277
-1,374
-8% -$13.5K
FPI
1286
Farmland Partners
FPI
$411M
$106K ﹤0.01%
12,000
-1,421
-11% -$11.8K
ACTG icon
1287
Acacia Research
ACTG
$426M
$104K ﹤0.01%
25,000
– –
EHI
1288
Western Asset Global High Income Fund
EHI
$175M
$102K ﹤0.01%
+11,182
New +$105K
MIE
1289
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
$102K ﹤0.01%
10,200
-6,400
-39% -$64.3K
WPG
1290
DELISTED
Washington Prime Group Inc.
WPG
$99K ﹤0.01%
1,350
– –
SBBP
1291
DELISTED
Strongbridge Biopharma plc.
SBBP
$89K ﹤0.01%
14,753
+1,317
+10% +$9.64K
RIOT icon
1292
Riot Platforms
RIOT
$8.36B
$82K ﹤0.01%
+13,000
New +$95.1K
RMTI icon
1293
Rockwell Medical
RMTI
$28M
$82K ﹤0.01%
152
-23
-13% -$13.8K
OPK icon
1294
Opko Health
OPK
$993M
$81K ﹤0.01%
17,314
-1,500
-8% -$5.69K
S
1295
DELISTED
Sprint Corporation
S
$76K ﹤0.01%
13,881
-210
-1% -$1.14K
VNRX icon
1296
VolitionRx Ltd
VNRX
$9.63M
$74K ﹤0.01%
+1,848
New +$82.6K
AXAS
1297
DELISTED
Abraxas Petroleum Corp
AXAS
$74K ﹤0.01%
1,275
– –
ATRS
1298
DELISTED
Antares Pharma, Inc.
ATRS
$66K ﹤0.01%
25,600
– –
ABDC
1299
DELISTED
Alcentra Capital Corp
ABDC
$65K ﹤0.01%
10,198
-641
-6% -$4.27K
JCP
1300
DELISTED
J.C. Penney Company, Inc.
JCP
$57K ﹤0.01%
24,400
+5,000
+26% +$14.1K
50 51
52
53 54

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.